TVTX Q2 2017 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M+16.5% YoY

Gross Profit

$38M97.9% margin

Operating Income

-$14M-35.0% margin

Net Income

-$13M-34.1% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+15.4%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$2M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$507M

Total Liabilities

$211M

Stockholders' Equity

$296M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$33M	+16.5%
Gross Profit	$38M	$32M	+17.7%
Operating Income	-$14M	-$11M	-19.5%
Net Income	-$13M	-$13M	+1.3%